MPLT Stock Analysis: Buy, Sell, or Hold?
$9.82
0.19 (1.97%)
▲
5d:
-6.12%
30d:
-24.81%
90d:
-71.97%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When MPLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MPLT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MPLT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MPLT is currently trading at $9.82, which is considered oversold relative to its 30-day fair value range of $10.58 to $13.25.
Technical Outlook: Technically, MPLT is in a strong downtrend. Immediate support is located at $9.43, while resistance sits at $11.28.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Implied Volatility is high (97th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $26.54 (+170.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MPLT is in a strong downtrend. Immediate support is located at $9.43, while resistance sits at $11.28.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Implied Volatility is high (97th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $26.54 (+170.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.58 -
$13.25
Company Quality Score
47/100
(HOLD)
Options IV Signal
97th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
65.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Options expensive (IV 97th percentile)
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 170.2% below Wall St target ($26.54)
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.58 -
$13.25
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$3.00
(30.6%)
Support & Resistance Levels
Support Level
$9.43
Resistance Level
$11.28
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.98
Wall Street Target
$26.54
(+170.2%)
Share & Embed Analysis
Last updated: October 02, 2026 6:58 PM ET
Data refreshes hourly during market hours. Next update: 7:58 PM
Data refreshes hourly during market hours. Next update: 7:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MPLT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 52 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 51 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
10 analysts |
$70 | 68 BUY |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
13 analysts |
$107 | 67 BUY |